Distribution Agreements in the Health Care Equipment & Supplies Industry
131 Contracts & Agreements
- ABIOMED Inc (1 contract)
- Acutus Medical, Inc. (3)
- Adams Respiratory Therapeutics, Inc. (2)
- Alphatec Holdings, Inc. (1)
- Angiodynamics Inc (1)
- Avanos Medical Inc (1)
- AxoGen, Inc. (3)
- BIOLASE, INC (1)
- BIOMIMETIC THERAPEUTICS, INC. (1)
- Bionik Laboratories Corp. (3)
- Bioventus Inc. (4)
- Cell MedX Corp. (1)
- Conformis Inc (1)
- CryoLife, Inc. (4)
- Cutera, Inc. (2)
- Cytosorbents Corp (3)
- DELCATH SYSTEMS, INC. (2)
- DEXCOM INC (15)
- EMULATE THERAPEUTICS, INC. (1)
- ESTABLISHMENT LABS HOLDINGS INC. (3)
- Heska Corporation (6)
- Hill-Rom Holdings Inc. (1)
- HYPERION THERAPEUTICS INC (2)
- ICU Medical (1)
- Innovative Eyewear Inc (1)
- Inogen, Inc. (3)
- InspireMD, Inc. (8)
- INSULET CORP (2)
- INVO Bioscience, Inc. (8)
- Longview Acquisition Corp. (1)
- Lucira Health, Inc. (2)
- Medite Cancer Diagnostics, Inc. (1)
- MRI INTERVENTIONS, INC. (1)
- NanoVibronix, Inc. (1)
- Neogen Corporation (1)
- Neuronetics, Inc. (2)
- NeuroPace Inc (1)
- OBALON THERAPEUTICS INC (2)
- OraSure Technologies, Inc. (4)
- OxySure Therapeutics, Inc. (3)
- Penumbra Inc (1)
- ReShape Lifesciences Inc. (3)
- ReWalk Robotics Ltd. (1)
- ROCKWELL MEDICAL, INC. (3)
- RTI SURGICAL, INC. (6)
- Senseonics Holdings, Inc. (4)
- Sharps Technology Inc. (1)
- Sintx Technologies, Inc. (1)
- SmileDirectClub, Inc. (1)
- STEMLINE THERAPEUTICS INC (1)
- TRANSENTERIX INC. (1)
- UTAH MEDICAL PRODUCTS INC (1)
- VERMILLION, INC. (1)
- ViewRay, Inc. (1)
- VIVEVE MEDICAL, INC. (1)
- Amendment Number Thirteen to Amended and Restated Non-Exclusive Distribution Agreement, dated June 1, 2023, by and between DexCom, Inc. and Byram Healthcare (DEXCOM INC, Filed With SEC on July 27, 2023)
- Amendment Number Eleven to Non-Exclusive Distribution Agreement, dated March 15, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (DEXCOM INC, Filed With SEC on July 27, 2023)
- Amendment Number Fourteen to Amended and Restated Non-Exclusive Distribution Agreement, dated April 1, 2023, by and between DexCom, Inc. and Byram Healthcare (DEXCOM INC, Filed With SEC on July 27, 2023)
- Amendment Number Twelve to Non-Exclusive Distribution Agreement, dated May 15, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (DEXCOM INC, Filed With SEC on July 27, 2023)
- Amendment Number Nine to Non-Exclusive Wholesale Distribution Agreement, dated February 1, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (DEXCOM INC, Filed With SEC on April 27, 2023)
- Amendment Number Ten to Non-Exclusive Distribution Agreement, dated February 1, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC (DEXCOM INC, Filed With SEC on April 27, 2023)
- Amendment Number Twelve to Amended and Restated Non-Exclusive Distribution Agreement, dated February 1, 2023, by and between DexCom, Inc. and Byram Healthcare (DEXCOM INC, Filed With SEC on April 27, 2023)
- Distribution Agreement with Ming Mei Technology Co. Ltd (INVO Bioscience, Inc., Filed With SEC on January 5, 2023)
- Distribution Agreement, dated December 8, 2022, by and among Sharps Technology, Inc., Nephron Pharmaceuticals Corporation and Nephron SC, Inc (Sharps Technology Inc., Filed With SEC on December 13, 2022)
- Exclusive Distribution Agreement, dated August 9, 2022, by and between the Company and DIXI Medical USA Corp (NeuroPace Inc, Filed With SEC on November 8, 2022)
- Distribution Agreement, dated November 7, 2022, by and among SmileDirectClub, Inc., SDC Financial LLC and UBS Securities LLC (SmileDirectClub, Inc., Filed With SEC on November 8, 2022)
- Clean-Trace(TM) Distribution Agreement, dated as of September 1, 2022, by and between 3M Company and Garden SpinCo Corporation (Neogen Corporation, Filed With SEC on September 1, 2022)
- Distribution Agreement, dated October 10, 2019, by and between EMulate Therapeutics, Inc. and Sayre Therapeutics Private Limited (EMULATE THERAPEUTICS, INC., Filed With SEC on August 16, 2022)
- Exclusive Distribution Agreement (INVO Bioscience, Inc., Filed With SEC on May 16, 2022)
- 2nd Amendment to the Global Alliance for Product Distribution Agreement dated April 25, 2022, by and between Biotronik SE & Co. KG and Acutus Medical, Inc (Acutus Medical, Inc., Filed With SEC on April 27, 2022)
- Amendment #1 to Distribution Agreement, dated December 21, 2021, by and between the registrant and Switch Health Solutions Inc (Lucira Health, Inc., Filed With SEC on March 31, 2022)
- Distribution Agreement, dated July 14, 2021, by and between the registrant and Switch Health Solutions Inc (Lucira Health, Inc., Filed With SEC on March 31, 2022)
- Amendment, effective January 1, 2022, to Distribution Agreement dated August 5, 2013, between Cutera Inc., and ZO Skin Health, Inc (Cutera, Inc., Filed With SEC on March 1, 2022)
- Distribution Agreement by and between Innovative Eyewear, Inc. and 8 Points Inc (Innovative Eyewear Inc, Filed With SEC on January 10, 2022)
- Second Amendment to the Exclusive Distribution Agreement entered into as of March 16, 2020 between the Company and Baxter Healthcare Corporation (ROCKWELL MEDICAL, INC., Filed With SEC on November 15, 2021)
- Private Label Distribution Agreement, by and between the Company and OxyGo HQ Florida, LLC, dated as of September 23, 2021 (Inogen, Inc., Filed With SEC on November 4, 2021)
- Amended and Restated Distribution Agreement for Private Label Products dated December 10, 2020 by and between NanoVibronix, Inc. and Ultra Pain Products Inc (NanoVibronix, Inc., Filed With SEC on April 15, 2021)
- Amendment No. 1 to Distribution Agreement (INVO Bioscience, Inc., Filed With SEC on March 8, 2021)
- First Amendment to Exclusive Distribution Agreement, by and between JOTEC GmbH, as distributor, and Endospan Ltd., as manufacturer, dated as of August 31, 2020 (CryoLife, Inc., Filed With SEC on February 23, 2021)
- Amended and Restated Exclusive Distribution Agreement No. 2 by and between Seikagaku Corporation and Bioventus LLC, effective December 22, 2020 (Bioventus Inc., Filed With SEC on January 20, 2021)
- Distribution Agreement (INVO Bioscience, Inc., Filed With SEC on December 8, 2020)
- Distribution Agreement, dated as of July 11, 2018, by and between Butterfly and Cardinal Health 105, Inc (Longview Acquisition Corp., Filed With SEC on November 27, 2020)
- Distribution Agreement (INVO Bioscience, Inc., Filed With SEC on November 25, 2020)
- Second Amendment to Exclusive Distribution Agreement by and between Establishment Labs S.A. and Puregraft LLC dated September 21, 2020 (ESTABLISHMENT LABS HOLDINGS INC., Filed With SEC on September 25, 2020)
- Bi-Lateral Distribution Agreement, dated May 11, 2020, between the Registrant and Biotronik SE & Co. KG (Biotronik as distributor) (Acutus Medical, Inc., Filed With SEC on July 15, 2020)
- Bi-Lateral Distribution Agreement, dated May 11, 2020, between the Registrant and Biotronik SE & Co. KG (Acutus as distributor) (Acutus Medical, Inc., Filed With SEC on July 15, 2020)
- Fifth Amendment to Distribution Agreement, by and among Senseonics, Incorporated, Roche Diagnostics International AG and Roche Diabetes Care GmbH, dated as of December 12, 2019 (Senseonics Holdings, Inc., Filed With SEC on March 16, 2020)
- Distribution Agreement by and between Chindex Shanghai International Trading Company Limited and ViewRay Technologies, Inc. dated November 29, 2019 (ViewRay, Inc., Filed With SEC on March 12, 2020)
- Distribution Services Agreement dated November 7, 2015 between DexCom, Inc. and AmerisourceBergen Drug Corporation (DEXCOM INC, Filed With SEC on February 13, 2020)
- Amendment to the Distribution Services Agreement between Dexcom Inc. and AmerisourceBergen Drug Corporation (DEXCOM INC, Filed With SEC on February 13, 2020)
- Distribution Agreement (Bionik Laboratories Corp., Filed With SEC on January 28, 2020)
- Distribution Agreement, dated as of September 30, 2019, by and between Howmedica Osteonics Corp. and Conformis, Inc (Conformis Inc, Filed With SEC on November 1, 2019)
- Exclusive Distribution Agreement, dated September 11, 2019, by and between JOTEC GmbH, as distributor, and Endospan Ltd., as manufacturer (CryoLife, Inc., Filed With SEC on October 31, 2019)
- The First Amendment dated August 9, 2019 to the Exclusive Distribution Agreement by and between Registrant, Puregraft LLC and its parent, Bimini Technologies, LLC, dated September... (ESTABLISHMENT LABS HOLDINGS INC., Filed With SEC on August 13, 2019)
- First amendment to the distribution agreement, by and between the Registrant and Teijin Pharma Limited, dated May 31, 2019 (Neuronetics, Inc., Filed With SEC on August 6, 2019)
